Cell surface markers are also expressed as cell surface antigens that provide monograms to find and categorise cells. The proteins expressed on the surface of cells usually suitable to serve as markers of specific cell types. There are certain combinations of markers or antigens can be detected through cell surface makers detection, in the distinct kinds of cells, this molecule identification aid in detection of diseases, and to observe the direct treatment for the disease, drug invention, and so on. It additionally helps in the calculation of cell type expression of particular receptors, necessary for biological response.
The study analysis of,’ Global Cell Surface Markers Detection Market is valued approximately USD 4.6 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.2% over the forecast period 2020-2026’ Companies are actively entering into strategic agreements and collaborations with other players in the industry to improve their product and increase visibility owing to strategic product placement. Some of the key market players are Abbott Laboratories, Beckman Coulter, Inc., BD Biosciences, BioRad Laboratories Inc., Grifols SA, Janssen Diagnostics, Inc, Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc. and Siemens Healthcare. Partnerships, product inaugurate, merger & acquisition, research and development are the competitive ways acquired by these players. The market is further segmented into type and applications. On the basis of type fragmented into Flow Cytometry, Haematology Analyzers, Cell Imaging Systems and Reagents and Kits. On the basis of application into Drug Discovery & Research, Disease Diagnosis & Identification and Others. Further, it may be advantageous in personalized medicine, in which it assists the physician to choose the most systematic therapy to be used for analysing and understanding the cells isolated from patients. Thus, increase in prevalence of cancer, rising funding for life science and stem cell research and the development in monoclonal antibody production and creation of cell-specific antibodies are the few factors responsible for high CAGR of the market over the forecast amount.
The geographical analysis of global Cell Surface Markers Detection market is considered for the key regions includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the foremost region across the globe with regards to market share because of rising number of R&D activities and surging use of cell surface markers in drug discovery and personalized medicine in the country. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate over the forecast amount, because of growing number of life sciences research activities and supportive government initiatives & grants to enhance the biotechnology and pharmaceutical industries in the countries such as China and India.
Moreover, the increase in a number of research projects for cell biology and molecular biology techniques is attributed to the predicted expansion in this sector. Also, rising incidence of different cell-associated and oncology diseases also drive the in vitro diagnostics demand relying on the principle of cell analysis and quantification and advancements in monoclonal antibody production and generation of cell-specific antibodies for diagnostic and prognostic usage are expected to boost growth. Furthermore, availability of reagents and staining dyes that are useful in specific cytological protocols are also attributed to the growth of market throughout the forecast amount.
For More Information, Click on the Link Below:-
Ankur Gupta, Head Marketing & Communications